Spots Global Cancer Trial Database for Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients
Official Title: Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients With Advanced Colorectal or Gastric Cancer Treated With FOLFIRI Regimen
Study ID: NCT01271582
Interventions
Study Description
Brief Summary: The purpose of this study is to investigate the association between UGT1A1 polymorphisms and neutropenia and diarrhea in Korean patients with advanced colorectal or gastric cancer treated with FOLFIRI regimen.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of
Hwasun Hospital, Chŏnam, Hwasun-gun, Korea, Republic of
Korea Cancer Center Hospital, Seoul, Nowon-Gu, Korea, Republic of
Asan Medical Center, Seoul, Songpa-Gu, Korea, Republic of
National Cancer Center, Goyang, , Korea, Republic of
Contact Details
Name: YongSang Hong, Professor
Affiliation: Asan Medical Center
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
